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Synchronous diagnosisLobular breast carcinoma involving the colon is a rare condition. Inmost cases reported in the literature, metastases
are detected after a 20-year latency period after the initial diagnosis. Here we describe a case in which metastatic
lobular breast carcinoma and colonic metastasis were simultaneously diagnosed—with only 4 days between the
two diagnoses. A 55-year-old woman underwent mammography and colonoscopy in the setting of the National
Cancer Screening Program. Amalignant nodule in the left breastwas detected, and core-biopsy revealed an invasive
lobular carcinoma. Simultaneously, numerous intestinalmicropolypswere sampled. Histological examination of the
latter showed tumor cells growing in cords and presenting signet-ring appearance, thereby conﬁrming metastatic
breast carcinoma. In cases such as the one described here, pathological diagnosis can be extremely difﬁcult and
deep biopsies are required. Metastatic breast cancer involving the colon can be considerably underestimated
because of the unspeciﬁcity of the clinical manifestations, the long latency period, and diverse radiological ﬁndings
that can lead tomisdiagnosis.We conclude that clinicians should rule out intestinalmetastasis in patients diagnosed
with breast cancer, especially the lobular type, and presenting non-speciﬁc abdominal symptoms.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Breast cancer is the most common malignancy among women, with
approximately 12% of all women developing this disease in their lifetimes
(based on 2010–2012 data from the National Cancer Institute). Although
the survival rate has increased considerably as a result of early detection
and improved treatment guidelines, breast cancer continues to cause
high morbidity and mortality. However, more than 30% of patients will
developmetastatic disease even after treatment [1,2]. Classic ductal carci-
noma of the breast usually metastasizes to the lung, liver, and brain. In
contrast, lobular carcinoma (LC) of the breast, which accounts for be-
tween 10 and 15% of breast neoplasms, metastasizes more frequently in
gynecological organs, peritoneum, retroperitoneum, and extrahepatic
gastrointestinal tract. Nevertheless, involvement of the latter is rare [3,4].
The diagnosis of LC metastasis to colon years after initial diagnosis
has been widely reported. However, in only a few cases is the diagnosisspital del Mar, Passeig Marítim
o-González).
c. This is an open access article under
et al., Lobular breast carcinom
doi.org/10.1016/j.ehpc.2016.0of the involvement of the two sites simultaneous. Herein, we report an
exceptional presentation of metastatic LC.
2. Case report
2.1. Clinical presentation
In the setting of the breast and colorectal National Cancer Screening
Program, a 55-year-old woman was referred to our hospital because of
detection of unilateral nipple retraction during self-examination and a
positive fecal occult blood test. Past medical history was unremarkable,
prior mammograms revealed no alterations, and no prior lower endos-
copies had been performed.
The mammograms showed left nipple retraction and a distorted
area measuring 68 × 65 mm, affecting the upper-external quadrant of
the left breast (Fig. 1). A core biopsy of the lesionwas performed, reveal-
ing an invasive classic-type lobular breast carcinoma (LC) (Fig. 2a). Im-
munohistochemical staining demonstrated that tumor cells showed
staining for cytokeratins (CAM5.2, Ventana, Roche, Tucson, Arizona,
USA) (Fig. 2b) as well as strong nuclear positivity for estrogen receptorthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1.Mammography. Parenchymal distorted area affecting the upper-external quadrant
of the left breast. Nipple retraction was also detected.
2 R. Albero-González et al. / Human Pathology: Case Reports xxx (2016) xxx–xxx(ER) (98%) (Fig. 2c) and progesterone receptor (PR) (98%) (Ventana,
Roche, Tucson, Arizona, USA), while staining for E-cadherin (Fig. 2d)
and p53 (Ventana, Roche, Tucson, Arizona, USA) was negative. Human
epidermal growth factor receptor 2 score (HER2) usingFig. 2.Microscopic ﬁndings of breast lesion. a. Histopathology viewof the left breast nodule: a lo
cytokeratin marker CAM 5.2 (b) and estrogen receptor (ER) (98%) (c) was strongly positive in
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around 1% (Ventana, Roche, Tucson, Arizona, USA).
Simultaneously, a colonoscopywas performed.We detected the pres-
ence of more than 100 plaque-shaped whitish micropolyps with a diam-
eter between1 and2mmalong the right and left large intestine but not in
the rectum (Fig. 3). Biopsies conﬁrmedmetastatic LC, consisting of a pop-
ulation of monomorphous and discohesive medium-sized cells with vac-
uolated cytoplasm, invading the lamina propria. Nuclei ranged from
round to slightly irregular, with ﬁne chromatin and inconspicuous nucle-
oli. Intracytoplasmic lumenswere also observed (Fig. 4a–b). An immuno-
histochemical study was performed in order to make a differential
diagnosis with other malignant tumors with a similar appearance, such
as intestinal ‘signet ring carcinoma’, and also with other benign growths,
such as intramucosal xanthomas. Tumoral cells showed strong cytoplas-
mic staining for cytokeratin AE1/AE3 (Diagnostic Biosystems, Palex Med-
ical, Pleasanton, California, USA), and cytokeratin 7 (Ventana, Roche,
Tucson, Arizona, USA). Nuclear ER immunostaining was positive (98%),
although PR was detected in only a few scattered cells. E-cadherin stain-
ing was negative (Fig. 4c–d). Immunohistochemical expression was not
detected for cytokeratin 20 or for CDX-2 (Ventana, Roche, Tucson, Arizo-
na, USA), thereby ruling out an intestinal origin. Tumoral cells were also
negative for histiocyticmarkers (CD68). The breast and colonpathological
reports were only 4 days apart.
2.2. Follow-up
Breast magnetic resonance imaging (MRI) and a thoraco-abdominal
computed tomography (CT) scan were performed one week later. The
images pointed to the involvement of the ipsilateral axillary lymphbular carcinoma is shown [H&E, ×200]. b, c and d. Immunohistochemical expression of the
tumor cells, but E-cadherin staining (d) was negative [immunostaining, ×200].
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Fig. 3. Colonoscopy revealingmultiple smallmicropolyps affecting the left and right colon-
ic mucosa.
3R. Albero-González et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxnodes and the presence of hepatic and peritoneal nodules. Fine-needle
aspiration cytology and a liver biopsy conﬁrmed that these structures
had been compromised. The patient underwent treatment with
paclitaxel-bevacizumab, achieving a partial response. However, this
treatmentwas interrupted a year later because of gastrointestinal intol-
erance. She was then put on letrozole-bevacizumab. A cranial CT scan
was performed 18 months post-diagnosis, revealing leptomeningealFig. 4.Microscopic ﬁndings of a colonic micropolyp sampled. a and b. Colonic biopsy revealed i
rounding glands and growing in cords (a). Highermagniﬁcation view of neoplastic cells (b) [H&
conﬁrmed the existence of metastatic breast disease. E-cadherin (d) immunoexpression was n
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ate. Subsequent CT scans of the brain, thorax, and abdomenwere unre-
markable, as were analytical parameters and serum tumor markers.
These observations gave no evidence of malignant recurrence at the
time of writing this report. The patient is now being treated with
letrozole. She shows good tolerance and is subjected to routine
monitoring.
3. Discussion
Breast cancer is one of the primarymalignancies thatmost frequent-
ly spread to the extrahepatic gastrointestinal tract. However, in only a
few cases breast carcinomametastases to colon have been diagnosed si-
multaneously [2].
Washington et al. reported on the most common secondary tumors
affecting the gastrointestinal tract in surgical specimens. According to
their results, these were malignant melanoma, ovary, bladder, breast,
and lung cancer, respectively [4]. The incidence of digestive systemme-
tastases from breast lobular carcinoma (LC) reported in autopsy studies
varies from approximately 7% to 17%, [4–6].
The period of time between the diagnosis of LC and colonmetastasis
ranges from a synchronous diagnosis, as in the case we are presenting,
to as long as 20–30 years, the latter being the most common presenta-
tion in most cases reported [2,7,8]. Stomach is the organ most affected
by extrahepatic gastrointestinal metastasis, followed by the small
bowel, colon, and rectum [9,10].
Clinical symptoms and signs of LC metastasis to the gastrointestinal
tract are frequently non-speciﬁc, usually mimicking inﬂammatorynvasiveness of lamina propria by a population of monomorphous medium-sized cells sur-
E, ×200 (a), ×400 (b)]. c and d. ER staining (c) highlighted the presence of tumor cells and
egative [immunostaining, ×200].
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4 R. Albero-González et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxbowel disease, diverticulitis, or primary colon cancer [11–13]. Radiolog-
ical and endoscopic features include mucosal nodularity and rigidity
and thickening of intestinal wall, as well as lobulation and deformity
caused by the presence of a mass [14]. The case that we present here
is exceptional as the patient was asymptomatic and the endoscopy
revealed multiple millimetric polyps mimicking a colonic polyposis.
Complicated cases with hemorrhage and/or stenotic lesions causing
obstruction require palliative surgery.
Pathological diagnosis of metastatic breast LC to gastrointestinal
tract can be quite difﬁcult, especially when samples are superﬁcial, rea-
son why deep biopsies are needed in most cases [1,7,8]. Occasionally, a
laparotomy may also be required to achieve histological conﬁrmation.
Metastatic LC has a typical pattern of invasion, with intramural inﬁltra-
tion throughout serosa, muscular propria and submucosa layers [1].
Tumor cells grow to form cords or small clusters and are medium-
sized with monomorphic, round nuclei, inconspicuous nucleoli, and
vacuolated cytoplasms. They commonly present a signet-ring appear-
ance [2]. To distinguish the metastasis from a primary intestinal
tumor, diagnosis is facilitated by the absence of dysplasia or nuclear
atypia in the colonic epithelium and by the presence of inﬁltrating tu-
moral cells surrounding the preexistent glands. However, immunohis-
tochemistry continues to be the best tool to achieve a precise
diagnosis, especially in those cases with available information on the
immunophenotype of the breast carcinoma (i.e. hormonal receptors
and/or HER2 overexpression). Of note, metastatic LC can show isolated
loss of ERs and PRs [15].
The incidence of metastatic LC may be underestimated because of
the non-speciﬁcity of the clinical, endoscopic and radiologic manifesta-
tions, and also due to the long latency after initial diagnosis and patient
death frommetastatic disease [2,8]. Therefore, it is important to consid-
er the contribution of metastatic breast neoplasm in women presenting
abnormal radiological results involving the digestive system [12] and
presenting microcytic anemia caused by fecal occult bleeding.
The case reported herein is exceptional due to the presentation of LC
with a synchronous diagnosis of gastrointestinal metastases in an infre-
quent location, such as the colon.
4. Conclusions
LC metastasis to colon is a rare condition that can be extremely dif-
ﬁcult to diagnose depending on the clinical manifestation. Given the in-Please cite this article as: R. Albero-González, et al., Lobular breast carcinom
Human Path Case Reports (2016), http://dx.doi.org/10.1016/j.ehpc.2016.0creased survival rate with current therapeutic measures, more unusual
disease presentations can occur. Hence, recognition of possiblemanifes-
tations is meaningful and should be considered in order to achieve an
accurate diagnosis and treatment.
Patients presenting vague abdominal symptoms and with a history
of breast cancer, particularly the lobular type, should be subjected to
an endoscopic examination in order to rule out metastases in this loca-
tion, even in cases when the initial diagnosis of LC was decades earlier.
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